Company No:
Contents
DIRECTORS | Benjamin Birrell |
Katie Louise Birrell | |
Tina Bolding (Resigned 20 August 2024) | |
Dawn Dowds | |
Beverley Jayne Harrow | |
Zeeus Roy Thomas Stone |
SECRETARY | Benjamin Birrell |
REGISTERED OFFICE | 4 The Traverse |
Bury St. Edmunds | |
IP33 1BJ | |
United Kingdom |
COMPANY NUMBER | 13060328 (England and Wales) |
CHARTERED ACCOUNTANTS | Gascoynes |
Gascoyne House | |
Moseleys Farm Business Centre | |
Fornham All Saints | |
Bury St Edmunds | |
Suffolk | |
IP28 6JY |
Note | 2024 | 2023 | ||
£ | £ | |||
Fixed assets | ||||
Investments | 3 |
|
|
|
480 | 1,520 | |||
Current assets | ||||
Stocks | 4 |
|
|
|
Debtors | 5 |
|
|
|
Cash at bank and in hand |
|
|
||
596,076 | 36,786 | |||
Creditors: amounts falling due within one year | 6 | (
|
(
|
|
Net current assets/(liabilities) | 563,919 | (70,582) | ||
Total assets less current liabilities | 564,399 | (69,062) | ||
Net assets/(liabilities) |
|
(
|
||
Capital and reserves | ||||
Called-up share capital |
|
|
||
Profit and loss account |
|
(
|
||
Total shareholders' funds/(deficit) |
|
(
|
Directors' responsibilities:
These financial statements have been prepared in accordance with the provisions of FRS 102 Section 1A – small entities. The financial statements of Haelan Pharmaceuticals Limited (registered number:
Dawn Dowds
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.
Haelan Pharmaceuticals Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 4 The Traverse, Bury St. Edmunds, IP33 1BJ, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.
2024 | 2023 | ||
Number | Number | ||
Monthly average number of persons employed by the Company during the year, including directors |
|
|
Other investments | Total | ||
£ | £ | ||
Cost or valuation before impairment | |||
At 01 January 2024 |
|
|
|
Disposals | (
|
(
|
|
At 31 December 2024 |
|
|
|
Carrying value at 31 December 2024 |
|
|
|
Carrying value at 31 December 2023 |
|
|
2024 | 2023 | ||
£ | £ | ||
Stocks |
|
|
2024 | 2023 | ||
£ | £ | ||
Amounts owed by Group undertakings |
|
|
|
Other debtors |
|
|
|
|
|
2024 | 2023 | ||
£ | £ | ||
Trade creditors |
|
|
|
Amounts owed to Group undertakings |
|
|
|
Other taxation and social security |
|
(
|
|
Other creditors |
|
|
|
|
|
Transactions with entities in which the entity itself has a participating interest
2024 | 2023 | ||
£ | £ | ||
Balances owed by subsidiaries - Pura Health Limited | 98,723 | 0 | |
Balances owed to subsidiaries - The Original Alternative (Guernsey) Limited | 0 | 109,583 | |
Balances owed by subsidiaries - Greenleaf Analytics Limited | 0 | 5,993 | |
Balances owed by subsidiaries - The Original Alternative Limited | 0 | 3,584 | |
Balances owed by subsidiaries - CBD Clinics Limited | 0 | 127 | |
Balances owed by subsidiaries - CBD Brothers Gsy Ltd | 0 | 125 | |
Balances owed by subsidiaries - Celebrated Limited | 0 | 867 | |
Balances owed by subsidiaries - Greenleaf Processing Limited | 208,786 | 13,436 |
Transactions with the entity's directors
2024 | 2023 | ||
£ | £ | ||
Amount owed to Director - D Dowds | 1,044 | (10) | |
Amount owed to Director - K Birrell | 0 | 35 | |
Amount owed by Director - T Bolding | 28,399 | 35 | |
Amount owed by Director - Z Stone | 786 | 0 | |
Amount owed by Director - B Birrell | 7,866 | (995) |